🔥🐔 BizChicken 🐔🔥
Companies Similar to Amylyx Pharmaceuticals, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Alector, Inc.
AL001, AL101, AL002, AL003, AL044
Alector, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for neurodegeneration diseases. The company has several products in various stages of clinical trials aimed at treating conditions such as Alzheimer's, Parkinson's, and frontotemporal dementia.
About | Vision/Values | History | Leadership | Contact | Culture | Vision/Values | History | About | About | About | About | Careers | About | About
Symbol: ALEC
Recent Price: $1.72
Industry: Biotechnology
CEO: Dr. Arnon Rosenthal Ph.D.
Sector: Healthcare
Employees: 245
Address: 131 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 415 231 5660
Leadership
- Arnon Rosenthal, Ph.D., Co-Founder, Chief Executive Officer, and Director
- Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development
- Marc Grasso, M.D., Chief Financial Officer
- Gary Romano, M.D., Ph.D., Chief Medical Officer
- Danielle Pasqualone, Ph.D., J.D., General Counsel
- Clare Hunt, M.B.A., Chief People Officer
- Kristina Cutter, M.P.H., Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
- Virginia DeJesus-Rueff, M.B.A., Chief of Staff and Head of Strategy
- Norah Conway, Senior Vice President, Portfolio and Program Management
- Neil Berkley, M.S., M.B.A., Chief Business Officer
- Louis J. Lavigne Jr., M.B.A., Chairperson of the Board
- Elizabeth Garofalo, M.D., Board Member
- Paula Hammond, Ph.D., Board Member
- Richard H. Scheller, Ph.D., Board Member
- David Wehner, Board Member
- Kristine Yaffe, M.D., Board Member
- Errol De Souza, Ph.D., Board Member
- Mark Altmeyer, M.B.A., Board Member
Last updated: 2024-12-31
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Lexicon Pharmaceuticals, Inc.
Sotagliflozin, LX9211
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products, with drugs like Sotagliflozin and LX9211 under development for heart failure, type 1 diabetes, and neuropathic pain.
About | Foundation | Leadership | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: LXRX
Recent Price: $0.72
Industry: Biotechnology
CEO: Dr. Michael Exton Ph.D.
Sector: Healthcare
Employees: 285
Address: 2445 Technology Forest Boulevard, The Woodlands, TX 77381
Phone: 281 863 3000
Leadership
- Brian Corrigan, Senior Vice President, Regulatory and Quality Assurance
- Brian Crum, Senior Vice President and General Counsel
- Lisa DeFrancesco, Vice President, Investor Relations and Corporate Communications
- Mike Exton, Ph.D., Chief Executive Officer and Director
- Tom Garner, Senior Vice President and Chief Commercial Officer
- Craig Granowitz, MD, PhD, Senior Vice President and Chief Medical Officer
- Alan Main, PhD, Executive Vice President, Innovation and Chemical Sciences
- Wendy McDermott, Senior Vice President, Human Resources
- Kristen Alexander, Vice President, Finance and Accounting
- Phillip Banks, MS, FRS, Vice President, Biostatistics and Data Management
- Kyle Burt, Vice President, Information Operations
- Amy Carroll, Ph.D., Vice President, Medical Affairs
- Melinda Francini, Vice President, Value and Access
- Desiree Gendron, Vice President, Sales and Training
- Suma Gopinathan, Ph.D., Vice President, Clinical Development
- Rachel Martens, Vice President, Partnerships and Corporate Strategy
- Nicole Moore, Vice President, Legal
- Tracy Newbold, Vice President, Clinical Operations
- Godfried Owusu-Ababio, Vice President, Technical Operations
- Rob Scala, Vice President, Business Planning and Commercial Operations
- Carrie Siragusa, Vice President, Marketing
- Dixon Terry, Vice President, Compliance
- Raymond Debbane, Chairman
- Philippe J. Amouyal,
- Samuel L. Barker, PhD,
- Robert J. Lefkowitz, MD,
- Christopher J. Sobecki,
- Diane E. Sullivan,
- Judith L. Swain, MD,
Last updated: 2024-12-31
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
ALX Oncology Holdings Inc.
ALX148
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.
About | Contact | About | About | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Careers | Jobs
Symbol: ALXO
Recent Price: $1.66
Industry: Biotechnology
CEO: Mr. Jason W. Lettmann
Sector: Healthcare
Employees: 81
Address: 323 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 466 7125
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Amylyx Pharmaceuticals, Inc.
AMX0035
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Their leading product, AMX0035, is aimed at ALS treatment.
About | Leadership | Directors | Contact | Careers | About | About | About | About | About | About | About | About | News | About
Symbol: AMLX
Recent Price: $3.84
Industry: Biotechnology
CEO: Mr. Joshua B. Cohen
Sector: Healthcare
Employees: 384
Address: 43 Thorndike Street, Cambridge, MA 02141
Phone: 617 682 0917
Leadership
- Linda A. Arsenault, Chief Human Resources Officer
- Camille L. Bedrosian, MD, Chief Medical Officer
- Josh Cohen, Co-CEO & Co-Founder
- James M. Frates, Chief Financial Officer
- Tom Holmes, Chief Technical Operations Officer
- Justin Klee, Co-CEO & Co-Founder
- Gina M. Mazzariello, Chief Legal Officer & General Counsel
- Rudolph Tanzi, PhD, Founding Chair of the Amylyx SAB
- Wally Gilbert, Special Advisor
- Kari Firestone, Director
- Paul Fonteyne, Director
- George Milne, Chairman
- Daphne Quimi, Director
- Bernhardt G. Zeiher, MD, FACP, FCCP, Director
Last updated: 2024-12-31
Ardelyx, Inc.
tenapanor
Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas, including treatments for irritable bowel syndrome with constipation and hyperphosphatemia.
About | Vision/Values | Leadership | About | About | About | About | Contact | About | About | About
Symbol: ARDX
Recent Price: $5.25
Industry: Biotechnology
CEO: Mr. Michael G. Raab
Sector: Healthcare
Employees: 267
Address: 400 Fifth Avenue, Waltham, MA 02451
Phone: 510 745 1700
Leadership
- Justin Renz, Chief Financial & Operations Officer
- Eric Foster, Chief Commercial Officer
- Elizabeth Grammer, Esq., Chief Legal & Administrative Officer
- Laura Williams, MD MPH, Chief Medical Officer
- Robert Blanks, MS RAC, Chief Regulatory Affairs & Quality Assurance Officer
- David Rosenbaum, PhD, Chief Development Officer
- Mike Kelliher, Executive Vice President, Corporate Development and Strategy
- Charon Spencer, Chief Human Resources Officer
- David Mott, Chairman
- Robert Bazemore, Director
- William A. Bertrand, Jr., JD, Director
- Muna Bhanji, R.Ph, Director
- Onaiza Cadoret-Manier, Director
- Mike Raab, Director
- Richard Rodgers, Director
Last updated: 2024-12-31
Anavex Life Sciences Corp.
ANAVEX 2-73
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.
Symbol: AVXL
Recent Price: $11.04
Industry: Biotechnology
CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Sector: Healthcare
Employees: 40
Address: 51 West 52nd Street, New York, NY 10019
Phone: 844 689 3939
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Lexeo Therapeutics, Inc. Common Stock
LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004
Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.
Symbol: LXEO
Recent Price: $6.54
Industry: Biotechnology
CEO: Mr. R. Nolan Townsend
Sector: Healthcare
Employees: 69
Address: 345 Park Avenue South, New York, null 10010
Phone: 212-547-9879
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Soligenix, Inc.
SGX301 (Hy Bryte), SGX942, SGX203, SGX302
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases, operating in the Specialized Bio Therapeutics and Public Health Solutions segments.
About | Directors | About | About | About | About | About | About | Contact | About | About | About | About | About | Careers | Careers | About | About | About | About | About | About | About
Symbol: SNGX
Recent Price: $2.91
Industry: Biotechnology
CEO: Dr. Christopher J. Schaber Ph.D.
Sector: Healthcare
Employees: 13
Address: 29 Emmons Drive, Princeton, NJ 08540
Phone: 609 538 8200
Leadership
- Christopher J. Schaber, PhD, Chairman, President and Chief Executive Officer
- Gregg A. Lapointe, CPA, MBA, Board Director
- Diane L. Parks, MBA, Board Director
- Robert J. Rubin, MD, Board Director
- Jerome Zeldis, MD, PhD, Board Director
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31